Starting from September 1, pharmacy employees may face heavy fines for not providing customers with complete information about available cheaper alternative medicines. This was reported by Zamin.uz.
This was announced by Aleksey Kubishkin, Associate Professor at Moscow State Law University. The new regulation is based on amendments included in the "Good Pharmacy Practice Rules in Medicine," approved by the Russian Ministry of Health and effective from September 1.
Although current legislation obliges pharmacy specialists and managers not to conceal information about the availability of cheaper drugs, the requirements were not clearly defined. Now, sanctions will be applied if such cases occur.
Employees who violate the rule may be fined from 100,000 to 200,000 rubles. This is considered a gross violation of the license.
Previously, it was proposed to introduce liability for pharmacists for incorrect approaches in drug selection. Research shows that in 60% of cases, pharmacy employees recommend medicines that have marketing agreements to customers.
This new regulation encourages pharmacy employees to ensure transparency and honesty when assisting customers in choosing medicines.
